Current and future treatment options for exon 14 skipping alterations in non-small cell lung cancer

Current and future treatment options for exon 14 skipping alterations in non-small cell lung cancer

It has been over three decades since the hepatocyte growth factor (HGF) ligand and its receptor MET proto-oncogene (MET) pathway was established as promoting cancer growth and metastasis. MET exon 14 skipping ( METex14 ) alterations occur in 3–4% of all non-small cell lung cancer (NSCLC) patients, t...

Full description

Bibliographic Details
Main Authors:	Lingzhi Hong, Jianjun Zhang, John V. Heymach, Xiuning Le
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-02-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758835921992976

Similar Items

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
by: Fujino T, et al.
Published: (2021-05-01)

MET Exon 14 Skipping Mutations in Non-small Cell Lung Cancer
by: Limei YIN, et al.
Published: (2018-07-01)

Non‐small cell lung cancer with mesenchymal–epithelial transition gene exon 14 skipping mutation treated with crizotinib
by: Seigo Katakura, et al.
Published: (2019-10-01)

MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population.
by: Jrhau Lung, et al.
Published: (2019-01-01)

Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
by: Jeroen Bremer, et al.
Published: (2019-12-01)

Mesenchymal-Epithelial Transition Exon 14 Skipping Mutation and Amplification in 5,008 Patients With Lung Cancer
by: Yaolin Song, et al.
Published: (2021-09-01)

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation
by: Shinkichi Takamori, et al.
Published: (2021-03-01)

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14
by: Hiroaki Kanemura, et al.
Published: (2021-02-01)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014-01-01)

Exon skipping as a therapeutic strategy in dysferlinopathy
by: Malcher, Jakub
Published: (2018)

Classifying Included and Excluded Exons in Exon Skipping Event Using Histone Modifications
by: Wei Chen, et al.
Published: (2018-10-01)

Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays
by: Yeh Ru-Fang, et al.
Published: (2008-11-01)

Lazarus Response to Tepotinib for Leptomeningeal Metastases in a Patient With MET Exon 14 Skipping Mutation–Positive Lung Adenocarcinoma: Case Report
by: Taira Ninomaru, MD, et al.
Published: (2021-03-01)

A compatible exon-exon junction database for the identification of exon skipping events using tandem mass spectrum data
by: Omenn Gilbert S, et al.
Published: (2008-12-01)

Combinatorial Pattern of Histone Modifications in Exon Skipping Event
by: Wei Chen, et al.
Published: (2019-02-01)

Variants affecting exon skipping contribute to complex traits.
by: Younghee Lee, et al.
Published: (2012-01-01)

Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene
by: Kane Greer, et al.
Published: (2020-06-01)

Therapeutic strategies in METex14 skipping mutated non-small cell lung cancer
by: Leylah M. Drusbosky, et al.
Published: (2021-08-01)

A Genotype-Phenotype Correlation Study of Exon Skip-Equivalent In-Frame Deletions and Exon Skip-Amenable Out-of-Frame Deletions across the <i>DMD</i> Gene to Simulate the Effects of Exon-Skipping Therapies: A Meta-Analysis
by: Saeed Anwar, et al.
Published: (2021-01-01)

Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non–small cell lung cancer patients in resource constrained community hospitals
by: Anurag Mehta, et al.
Published: (2021-09-01)

Deleterious c-Cbl Exon Skipping Contributes to Human Glioma
by: Min Woo Seong, et al.
Published: (2015-06-01)

Aberrant Single Exon Skipping is not Altered by Age in Exons of NF1, RABAC1, AATF or PCGF2 in Human Blood Cells and Fibroblasts
by: Markus Lamla, et al.
Published: (2011-08-01)

CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust
by: Dafeng Chen, et al.
Published: (2018-09-01)

Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib
by: Tan AC, et al.
Published: (2021-03-01)

Exon skipping-rich transcriptomes of animals reflect the significance of exon-shuffling in metazoan proteome evolution
by: Laszlo Patthy
Published: (2019-01-01)

MET exon 14 skipping mutation, amplification and overexpression in pulmonary sarcomatoid carcinoma: A multi-center study
by: Xue-wen Liu, et al.
Published: (2020-12-01)

Exon Skipping in a Dysf-Missense Mutant Mouse Model
by: Jakub Malcher, et al.
Published: (2018-12-01)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
by: Sue Fletcher, et al.
Published: (2012-01-01)

Unexpected consequences: exon skipping caused by CRISPR-generated mutations
by: Joshua J. Sharpe, et al.
Published: (2017-06-01)

Exploring association between microRNAs and exon skipping events
by: Yi-Yia Huang, et al.
Published: (2005)

Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
by: van Ommen Gert Jan B, et al.
Published: (2011-04-01)

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
by: van Ommen Gert-Jan B, et al.
Published: (2007-07-01)

Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples
by: Odharnaith O’Brien, et al.
Published: (2019-01-01)

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
by: Zhi Yon Charles Toh, et al.
Published: (2016-01-01)

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
by: Haiwei Mou, et al.
Published: (2017-06-01)

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
by: Yin, Hao, et al.
Published: (2019)

Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening.
by: Debra A O'Leary, et al.
Published: (2009-12-01)

MET Exon 14 Skipping: A Case Study for the Detection of Genetic Variants in Cancer Driver Genes by Deep Learning
by: Vladimir Nosi, et al.
Published: (2021-04-01)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
by: Li Liu, et al.
Published: (2021-06-01)

Development of an antisense-mediated exon skipping therapeutic strategy for Mucolipidosis II
by: Regina Filipa Machado Vilela
Published: (2019)